Genezen News & Resources

Keep up to date with the latest news at Genezen, and explore our expert content around molecular biology news and insights.

Scroll Down

Filter

By type

By service

Premium content

LVV Approaches to Pseudotyping and Plasmid…

As cell and gene therapies continue to provide unprecedented advancements in...

Read more

Genezen Announces the Appointment of Steven…

BOSTON, MA and FISHERS, IN. – March 13, 2023 – Genezen,...

Read more

Understanding the requirements of viral vector…

Analytical method development, qualification, and validation are an integral part of...

Read more

4 factors driving the trend towards…

The cell and gene therapy (C&GT) space is expanding rapidly. With...

Read more

Downstream Process Development for Lentiviral Vectors…

Lentiviral vectors (LVV) are commonly used as an efficient and safe...

Read more

Stable cell lines vs transient transfection…

The aim of upstream processing in viral vector development and manufacturing...

Read more
Load more

Get insights like this directly to your inbox

Sign up to our newsletter

Our solutions

From Process Development, Testing, GMP Vector Manufacturing to Cell Manufacturing

Our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to market with precision and speed.